Analysis of CDKN2A, CDKN2B, CDKN2C, and cyclin Ds gene status in hepatoblastoma

Hepatology

Volumn 27, Issue 4, 1998, Pages 989-995

  Iolascon, Achille ^a,d   Giordani, Lucia ^a   Moretti, Arcangela ^a   Basso, Giuseppe ^b   Borriello, Adriana ^c   Ragione Della, Fulvio ^c  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; MESSENGER RNA;

ALLELE; ARTICLE; CHROMOSOME 1P; CHROMOSOME 9P; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE EXPRESSION; HEPATOBLASTOMA; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; MALE; MALIGNANT TRANSFORMATION; POINT MUTATION; PRESCHOOL CHILD; PRIORITY JOURNAL;

CARRIER PROTEINS; CELL CYCLE PROTEINS; CHILD, PRESCHOOL; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P18; CYCLINS; ENZYME INHIBITORS; FEMALE; GENES, P16; HEPATOBLASTOMA; HUMANS; IMMUNOBLOTTING; INFANT; LIVER NEOPLASMS; LOSS OF HETEROZYGOSITY; MALE; RNA, MESSENGER; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 0031923034     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510270414     Document Type: Article

References (16)

1. Exelby PR, Filler RM, Grosfeld JL. Liver tumors in children in the particular reference to hepatoblastoma and hepatocellular carcinoma. Am Acad Pediatr Surg Sec Sur J Pediatr Surg 1975;10:329-337.
2. Simms LA, Reeve AE, Smith PJ. Genetic mosaicism at the insulin locus in liver associated with childhood hepatoblastoma. Genes Chromosomes Cancer 1995;13:72-73.
3. Byrne J, Simms L, Little M, Algar E, Smith P. Three nonoverlapping regions of chromosome arm 11p allele loss identified in infantile tumours of the adrenal and liver. Genes Chromosomes Cancer 1993;8: 101-111.
4. Kurahashi H, Takami K, Oue T, Kusafuka T, Okada A, Tawa A, Okada S, et al. Biallelic inactivation of the APC gene in hepatoblastoma. Cancer Res 1995;55:5007-5011.
5. INK4 in Hepatocellular Carcinoma. HEPATOLOGY 1996; 24:575-579.
6. Hunter T, Pines J. Cyclins and cancer II: cliclyn D and CDK inhibitors come to age. Cell 1994;79:573-582.
7. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993;366: 704-707.
8. Strauss M, Lukas J, Bartek J. Unrestricted cell cycling and cancer. Nat Med 1995;1:1245-1246.
9. Cairns P, Mao L, Merlo A, Lee DJ, Schwab D, Eby Y, Tokino K, et al. Rates of p16 (MTS1) mutations in primary tumors with 9p loss. Science 1994;265:415-417.
10. Okamoto A, Demetrick DJ, Spillare EA, Hagiwara K, Hussain SP, Bennett WP, Forrester K, et al. Mutations and altered expression of p16 in human cancer. Proc Natl Acad Sci USA 1994;91:11045-11049.
11. Kamb A, Grui NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavitgian SV, Stockert E, et al. A cell cycle regulatory potentially involved in genesis of many tumor types. Science 1994;264:436-440.
12. Takeuchi S, Bartram CR, Seriu T, Miller CW, Tobler A, Janssen JWG, Reiter A, et al. Analysis of a family of cyclin-dependent kinase inhibitors: p15/MTS2/INK4B, p16/MTS2/INK4A, and p18 genes in acute lymphoblastic leukemia of childhood. Blood 1995;86:755-760.
13. Iolascon A, Faienza M, Coppola B, Della Ragione F, Santoro N, Schettini E High frequency of homozygous deletions of CDK4I gene in childhood acute lymphoblastic leukemia. Brit J Haematol 1995;91:647-651.
14. Schimdt EE, Ichimura K, Reifenberger G, Collins VP. CDKN2 (p16/ MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastoma. Cancer Res 1994;54:6321-6324.
15. Caldas A, Hanh SA, da Costa LT, Redston RS, Schutte M, Seymour AB, Weinstein CL, et al. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat Genet 1994;8:27-32.
16. Hussussian CJ, Struewing JP, Goldstein AM, Higgins PAT, Ally DS, Sheahan MD, Clark WH Jr, et al. Germline p16 mutations in familial melanoma. Nat Genet 1994;8:15-21.